Literature DB >> 11798156

Down-regulation of macrophage CD9 expression by interferon-gamma.

Xue-Qing Wang1, Glenn F Evans, M Leticia Alfaro, Steven H Zuckerman.   

Abstract

CD9, a member of the tetraspanin family is a cell surface marker expressed on myeloid and nonmyeloid as well as on neoplastic cells. The present study has focused on the role of inflammation and macrophage activation in the regulation of CD9 expression. We report that the expression of CD9 on primary cultures of murine peritoneal macrophages was down regulated by Interferon-gamma, IFN-gamma. This down regulation was concentration-dependent and maximal by 48 h. The changes in surface expression were consistent with similar reductions in CD9 protein and message levels by Western and Northern blot analyses. The mechanism by which IFN-gamma decreases CD9 expression appears to be through the Stat1 signaling pathway as Stat1 knockout mice did not demonstrate any reduction in CD9 expression by IFN-gamma treatment. These results represent the first evidence for the down regulation of CD9 expression with macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11798156     DOI: 10.1006/bbrc.2001.6293

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Interferon-gamma reduces cell surface expression of annexin 2 and suppresses the invasive capacity of prostate cancer cells.

Authors:  Claire Hastie; John R Masters; Stephen E Moss; Soren Naaby-Hansen
Journal:  J Biol Chem       Date:  2008-01-22       Impact factor: 5.157

2.  Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease.

Authors:  Renat Shaykhiev; Anja Krause; Jacqueline Salit; Yael Strulovici-Barel; Ben-Gary Harvey; Timothy P O'Connor; Ronald G Crystal
Journal:  J Immunol       Date:  2009-07-27       Impact factor: 5.422

3.  Gene expression patterns induced by HPV-16 L1 virus-like particles in leukocytes from vaccine recipients.

Authors:  Alfonso J García-Piñeres; Allan Hildesheim; Lori Dodd; Troy J Kemp; Jun Yang; Brandie Fullmer; Clayton Harro; Douglas R Lowy; Richard A Lempicki; Ligia A Pinto
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 4.  Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages.

Authors:  Marco Orecchioni; Yanal Ghosheh; Akula Bala Pramod; Klaus Ley
Journal:  Front Immunol       Date:  2019-05-24       Impact factor: 7.561

5.  Tetraspanins CD9 and CD81 function to prevent the fusion of mononuclear phagocytes.

Authors:  Yoshito Takeda; Isao Tachibana; Kenji Miyado; Masatoshi Kobayashi; Toru Miyazaki; Toshiki Funakoshi; Hiromi Kimura; Hiroyuki Yamane; Yoshiyuki Saito; Hiroyuki Goto; Tsutomu Yoneda; Mitsuhiro Yoshida; Toru Kumagai; Tadashi Osaki; Seiji Hayashi; Ichiro Kawase; Eisuke Mekada
Journal:  J Cell Biol       Date:  2003-06-09       Impact factor: 10.539

Review 6.  CD9 Tetraspanin: A New Pathway for the Regulation of Inflammation?

Authors:  Carole Brosseau; Luc Colas; Antoine Magnan; Sophie Brouard
Journal:  Front Immunol       Date:  2018-10-09       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.